Question · asked by 1 review
Clotrimazole (partially absorbed from GI tract) vs another azole: Significant adverse events
- Population
- patients with otomycosis
- Intervention
- Clotrimazole (partially absorbed from GI tract)
- Comparison
- another azole
- Outcome
- Significant adverse events
What each review found
Current versions only| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Clotrimazole vs another azole Significant adverse events · patients with otomycosis Topical azole treatments for otomycosis (2021) · Cochrane Headline outcomes only | no estimate extracted | 1 study · 174 participants | Very low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Topical azole treatments for otomycosis 2021 · Cochrane Headline outcomes only | Not reported | Not extracted | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.